Physician profile
Eric Padron
NPI 1003904889
$54,339.20
in general payments reported to CMS, 2019-2025
11 companies · $5,849 in 2025
The $5,849 reported for 2025 was more than what 75% of Medical Oncology providers received nationally (typical 2025 total: $1,158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $8,868 · 2020: $18K · 2021: $5,924 · 2022: $5,361 · 2023: $10K · 2024: $101 · 2025: $5,849.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $11K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $4,631 · Food and Beverage: $133.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $11,441.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $4,631.25 |
| Food and Beverage | $133.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $17,781.44 | 2019-2021 | |
| Blueprint Medicines Corporation | $10,890.89 | 2020-2024 | Ayvakit |
| Taiho Oncology, INC. | $9,466.25 | 2020 | |
| Glaxosmithkline, LLC. | $6,500.00 | 2023 | |
| Geron Corporation | $4,631.25 | 2025 | Imetelstat |
| Cti Biopharma Corp. | $3,080.00 | 2023 | Vonjo |
| E.R. Squibb & Sons, L.L.C. | $1,186.00 | 2025 | |
| Abbvie INC. | $675.00 | 2023 | |
| Celgene Corporation | $96.20 | 2019 | |
| Sobi, INC | $32.17 | 2025 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Padron listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.